Adalimumab/infliximab/natalizumabHepatosplenic T-cell lymphoma: 25 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2012年 / 1385卷 / 1期

关键词：

Rheumatoid Arthritis; Methotrexate; Ulcerative Colitis; Infliximab; Adalimumab;

D O I：

10.2165/00128415-201213850-00013

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：6 / 6

相关论文

共 50 条

[1] Adalimumab/infliximabHepatosplenic T-cell lymphoma: 8 case reports
Reactions Weekly, 2009, 1265 (1) : 5 - 5
[2] Adalimumab/azathioprineHepatosplenic T-Cell lymphoma: case report
Reactions Weekly, 2019, 1774 (1) : 18 - 18
[3] Adalimumab/etanerceptHepatosplenic T-cell lymphoma: case report
Reactions Weekly, 2020, 1797 (1) : 16 - 16
[4] Adalimumab/Elasomeran/MethotrexateAngioimmunoblastic T-cell lymphoma : case report
Reactions Weekly, 2024, 2020 (1) : 20 - 20
[5] Infliximab/Mercaptopurine/VedolizumabHepatosplenic T-cell lymphoma: case report
Reactions Weekly, 2025, 2044 (1) : 165 - 165
[6] AzathioprineHepatosplenic T-cell lymphoma: 2 case reports
Reactions Weekly, 2016, 1622 (1) : 36 - 36
[7] Multiple drugsHepatosplenic T-cell lymphoma: case reports
Reactions Weekly, 2022, 1909 (1) : 370 - 370
[8] RituximabAppearance of T-cell lymphoma: 2 case reports
Reactions Weekly, 2008, 1213 (1) : 31 - 31
[9] Infliximab/methotrexateAdult T-cell leukaemia-lymphoma: case report
Reactions Weekly, 2018, 1726 (1) : 207 - 207
[10] Ciclosporin/tacrolimusCutaneous T-cell lymphoma: 2 case reports
Reactions Weekly, 2010, 1310 (1) : 16 - 16

← 1 2 3 4 5 →